# Evaluation of the General Population's Knowledge Concerning Liver Health: A Cross-Sectional Study

**Authors:** Hidar Alibrahim, Haidara Bohsas, Sarya Swed, Khaled Albakri, Yossef H AbdeQadir, Sara Ramadan, Lazaward Kazan, Heba Haj Saleh, Fatema Ali Asgar Tashrifwala, Mohamad Al Ibrahim, Sabine Tayfour, Touka Abo Alsel, Abdullah Alnehlawi, Ubaid Khan, Ashraf N.B. Boktor, Ibrahim Elbialy, Hekmieh Manad, Reem Rizk Abazid, Wael Hafez

PMC · DOI: 10.7759/cureus.54162 · 2024-02-14

## TL;DR

This study assesses Syrians' knowledge of liver health and finds moderate awareness, with gaps in understanding chronic liver disease risks and screening.

## Contribution

The study provides new insights into liver health awareness in Syria, highlighting demographic factors influencing knowledge and attitudes.

## Key findings

- Two-thirds of participants recognized hepatitis B and C as viral diseases, but 7% were unaware of their potential to cause chronic liver inflammation or failure.
- Males showed lower knowledge and less favorable attitudes toward liver health compared to females.
- Educational level, occupation, and gender significantly influenced participants' knowledge and attitudes toward liver health.

## Abstract

Introduction: Liver disease is among the leading causes of global mortality and morbidity. Given their substantial impact on public health, raising awareness about liver diseases is paramount for their prevention and effective management. This study aimed to evaluate the knowledge, awareness, attitudes, and behaviors of Syrians regarding liver health, chronic liver disorders, and their associated serious and irreversible complications.

Methods: We conducted a cross-sectional study encompassing the adult Syrian population between August 25 and September 29, 2023, excluding non-Syrians and individuals below the age of 18 years. A validated questionnaire, adapted from a previous study, was employed, consisting of 31 questions that covered topics related to knowledge and awareness of liver health and diseases (3-point Likert scale), attitudes towards liver screening, diagnosis, and treatment, and awareness of treatment options and vaccination. Statistical analysis including logistic regression was conducted using Statistical Product and Service Solutions (SPSS, version 28; IBM SPSS Statistics for Windows, Armonk, NY), with statistical significance set established at pp-values below 0.05.

Results: This study included 941 participants, with an average age of 26.5 years. While two-thirds of respondents demonstrated awareness of hepatitis B and C as viral diseases (663 (70.4%) and 612 (65.4%), respectively), approximately 66 (7%) were unaware of the potential for hepatitis to induce chronic liver inflammation or lead to liver failure. Over half of the participants were knowledgeable about the non-genetic nature of hepatitis B and C, and 579 (61.7%) were informed about the transmission risks associated with these infections. The most common reason cited for not participating in health screening tests was the perception of being in good health (219, 77.4%), and prescription medication was the most frequently sought treatment for hepatitis (543, 83.9%). Bivariate analysis revealed correlations between participant knowledge and sex, socioeconomic status, educational level, and occupation (P < 0.05). Similarly, the study identified significant associations between participant attitudes and age, gender, economic status, job, and educational level (P < 0.05). Moreover, the multivariate analysis demonstrated that gender, occupation, and educational level significantly influenced both participants’ knowledge and attitudes. Specifically, males exhibited lower knowledge and less favorable attitudes than females (P = 0.041 and P < 0.001, respectively).

Conclusion: The Syrian population possessed moderate knowledge of liver health and liver disorders. To bridge this knowledge gap and enhance preventive measures, it is recommended that additional health programs and awareness initiatives be implemented, involving healthcare providers and leveraging their expertise.

## Linked entities

- **Diseases:** hepatitis B (MONDO:0005344), liver disease (MONDO:0005154), liver failure (MONDO:0100192)

## Full-text entities

- **Diseases:** viral diseases (MESH:D014777), Liver disease (MESH:D008107), hepatitis B and C (MESH:D006509), hepatitis (MESH:D056486), chronic liver inflammation (MESH:D007249), liver (MESH:D017093)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10940955/full.md

---
Source: https://tomesphere.com/paper/PMC10940955